HCG18, LEF1AS1 and lncCEACAM21 as biomarkers of disease severity in the peripheral blood mononuclear cells of COVID-19 patients

BACKGROUND: Even after 3 years from SARS-CoV-2 identification, COVID-19 is still a persistent and dangerous global infectious disease. Significant improvements in our understanding of the disease pathophysiology have now been achieved. Nonetheless, reliable and accurate biomarkers for the early stra...

Descripción completa

Detalles Bibliográficos
Autores principales: Greco, Simona, Made’, Alisia, Mutoli, Martina, Zhang, Lu, Piella, Santiago Nicolas, Vausort, Mélanie, Lumley, Andrew I., Beltrami, Antonio Paolo, Srivastava, Prashant Kumar, Milani, Valentina, Boveri, Sara, Ranucci, Marco, Renna, Laura Valentina, Firat, Hüseyin, Bruno, Antonino, Spinetti, Gaia, Emanueli, Costanza, Devaux, Yvan, Martelli, Fabio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10605335/
https://www.ncbi.nlm.nih.gov/pubmed/37884975
http://dx.doi.org/10.1186/s12967-023-04497-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10605335/
https://www.ncbi.nlm.nih.gov/pubmed/37884975
http://dx.doi.org/10.1186/s12967-023-04497-6

Ejemplares similares